IGF-1 Deficiency in Combination with a Low Basic hBD-2 and hBD-3 Gene Expression Might Counteract Malignant Transformation in Pleomorphic Adenomas in Vitro

REFERENCES

• Machtens E. Speicheldrüsenerkrankungen. Mund Kiefer Gesichts Chir 2000;4:401–413.
   Google Scholar
• Röser K, Jakel KT, Herbst H, Loning, T. Immunohistochemical characterization of salivary gland tumors with tissue micro-arrays. Pathologe 2005 Sep;26(5):345–352.
   PubMed Web of Science ®Google Scholar
• Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Loning, T. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer 2005 Jun 15;103(12):2526–2533.
   PubMed Web of Science ®Google Scholar
• Pantelis A, Wenghoefer M, Haas S, Merkelbach-Bruse S, Pantelis D, Jepsen S, Bootz F, Winter J. Down regulation and nuclear localization of human beta-defensin-1 in pleomorphic adenomas of salivary glands. Oral Oncol 2009 Jun;45(6):526–530.
   PubMed Web of Science ®Google Scholar
• Wenghoefer M, Pantelis A, Dommisch H, Reich R, Martini M, Allam JP, Novak N, Bergé S, Jepsen S, Winter J. Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg 2008a Jul;37(7):660–663. Epub 2008 Mar 17.
   PubMed Web of Science ®Google Scholar
• Wenghoefer M, Pantelis A, Dommisch H, Götz W, Reich R, Bergé S, Martini M, Allam JP, Jepsen S, Merkelbach-Bruse S, Fischer HP, Novak N, Winter J. Nuclear hBD-1 accumulation in malignant salivary gland tumors. BMC Cancer 2008b Oct 7;8:290.
   PubMedGoogle Scholar
• Wenghoefer M, Pantelis A, Najafi T, Deschner J, Allam JP, Novak N, Reich RH, Martini M, Bergé S, Jepsen S, Winter J. Gene expression of oncogenes, antimicrobial peptides and cytokines in the development of oral leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Sep;110(3):351–356.
   PubMed Web of Science ®Google Scholar
• Winter J, Pantelis A, Reich R, Martini M, Kraus D, Jepsen S, Allam JP, Novak N, Wenghoefer M. Human beta-defensin-1, -2 and -3 exhibit opposite effects on oral squamous cell carcinoma cell proliferation. Cancer Invest 2011 Mar; 29(3):196–201.
   PubMed Web of Science ®Google Scholar
• Kraus D, Deschner J, Jäger A, Wenghoefer M, Bayer S, Jepsen S, Allam J, Novak N, Meyer R, Winter J. Human β-defensins differently affect proliferation, differentiation, and mineralization of osteoblast-like MG63 cells. J Cell Physiol 2011 Apr 25. doi: 10.1002 /jcp.22808.
   Web of Science ®Google Scholar
• Werner H, Bruchim I. The insulin-like growth factor-I receptor as an oncogene. Arch Physiol Biochem 2009 May;115(2):58–71. Review.
   PubMedGoogle Scholar
• Gallagher EJ, LeRoith D. The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab 2010 Oct;21(10):610–618. Epub 2010 Jul 19. Review.
   PubMed Web of Science ®Google Scholar
• Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008;8:915–928.
   PubMed Web of Science ®Google Scholar
• Dossus L, Kaaks, Best R. Nutrition, metabolic factors and cancer risk. Pract Res Clin Endocrinol Metab 2008;22:551–571.
   PubMed Web of Science ®Google Scholar
• Kesting MR, Loeffelbein DJ, Hasler RJ, Wolff KD, Rittig A, Schulte M, Hirsch T, Wagenpfeil S, Jacobsen F, Steinstraesser L. Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. Cancer Invest 2009;27(5):575–581.
   PubMed Web of Science ®Google Scholar
• Dommisch H, Acil Y, Dunsche A, Winter J, Jepsen S. Differential gene expression of human beta-defensins (hBD-1, -2, -3) in inflammatory gingival diseases. Oral Microbiol Immunol 2005;20(3):186–190.
   PubMedGoogle Scholar
• Dommisch H, Winter J, Willebrand C, Eberhard J, Jepsen S. Immune regulatory functions of human beta-defensin-2 in odontoblast-like cells. Int Endod J 2007 Apr;40(4):300–307. Epub 2007 Feb 8.
   PubMed Web of Science ®Google Scholar
• Dunsche A, Acil Y, Dommisch H, Siebert R, Schroder JM, Jepsen S. The novel human beta-defensin-3 is widely expressed in oral tissues. Eur J Oral Sci 2002;110(2):121–124.
   PubMed Web of Science ®Google Scholar
• Donald CD, Sun CQ, Lim SD, Macoska J, Cohen C, Amin MB, Young AN, Ganz TA, Marshall FF, Petros JA. Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Lab Invest 2003 Apr;83(4):501–505.
   PubMed Web of Science ®Google Scholar
• Sun CQ, Arnold R, Fernandez-Golarz C, Parrish AB, Almekinder T, He J, Ho SM, Svoboda P, Pohl J, Marshall FF, Petros JA. Human {beta}-Defensin-1, a potential chromosome 8p tumor suppressor: control of Transcription and induction of apoptosis in renal cell carcinoma. Cancer Res 2006 1;66(17):8542–8549.
   PubMed Web of Science ®Google Scholar
• Joly S, Compton LM, Pujol C, Kurago ZB, Guthmiller JM. Loss of human beta-defensin 1,2, and 3 expression in oral squamous cell carcinoma. Oral Microbiol Immunol 2009;24:353–360.
   PubMedGoogle Scholar
• Yoshimoto T, Yamaai T, Mizukawa N, Sawaki K, Nakano M, Yamachika E, Sugahara T. Different expression patterns of beta-defensins in human squamous cell carcinomas. Anticancer Res 2003;23:4629–4633.
   PubMed Web of Science ®Google Scholar
• Mizukawa N, Sawaki K, Yamachika E, Fukunaga J, Ueno T, Takagi S, Sugahara T. Presence of human beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res 2000;20:2005–2007.
   PubMed Web of Science ®Google Scholar
• Sawaki K, Mizukawa N, Yamaai T, Yoshimoto T, Nakano M, Sugahara T. High concentration of beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res 2002;22:2103–2107.
   PubMed Web of Science ®Google Scholar
• Nishimura M, Abiko Y, Kurashige Y, Takeshima M, Yamazaki M, Kusano K, Saitoh M, Nakashima K, Inoue T, Kaku T. Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines. J Dermatol Sci 2004;26:87–95.
   Google Scholar
• Forst B, Hansen MT, Klingelhöfer J, Møller HD, Nielsen GH, Grum-Schwensen B, Ambartsumian N, Lukanidin E, Grigorian M. Metastasis-inducing S100A4 and RANTES cooperate in promoting tumor progression in mice. PLoS One. 2010 Apr 28;5(4):e10374.
   Google Scholar
• Watson PH, Leygue ER, Murphy LC. Psoriasin (S100A7). Int J Biochem Cell Biol 1998 May;30(5):567–571.
   PubMed Web of Science ®Google Scholar
• Leygue E, Snell L, Hiller T, Dotzlaw H, Hole K, Murphy LC, Watson PH. Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res 1996 Oct 15;56(20):4606–4609. Erratum in: Cancer Res 1997 Feb 15;57(4):793.
   PubMed Web of Science ®Google Scholar
• Peng H, Shintani S, Kim Y, Wong DT. Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-beta-Smad signaling pathway. Neoplasia 2006 Dec;8(12):1028–1036.
   PubMed Web of Science ®Google Scholar
• Shintani S, Mihara M, Terakado N, Nakahara Y, Matsumura T, Kohno Y, Ohyama H, McBride J, Kent R, Todd R, Tsuji T, Wong DT. Reduction of p12DOC-1 expression is a negative prognostic indicator in patients with surgically resected oral squamous cell carcinoma. Clin Cancer Res 2001 Sep;7(9):2776–2782.
   PubMed Web of Science ®Google Scholar
• Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011 Jan;11(1):9–22. Epub 2010 Dec 16.
   PubMed Web of Science ®Google Scholar
• Pfaffl. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:2002–2007.
   Web of Science ®Google Scholar
• Weber A, Langhanki L, Schutz A, Gerstner A, Bootz F, Wittekind C. Expression profiles of p53, p63, and p73 in benign salivary gland tumors. Virchows Arch 2002;441:428–436.
   PubMed Web of Science ®Google Scholar
• Sheedy SP, Welker KM, DeLone DR, Gilbertson JR. CNS metastases of carcinoma ex pleomorphic adenoma of the parotid gland. AJNR Am J Neuroradiol 2006 Aug;27(7):1483–1485.
   PubMed Web of Science ®Google Scholar
• Foschini MP, Marucci G, Eusebi V. Low-grade mucoepidermoid carcinoma of salivary glands: characteristic immunohistochemical profile and evidence of striated duct differentiation. Virchows Arch 2002;440:536–542.
   PubMed Web of Science ®Google Scholar
• Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998;279:563–566.
   PubMed Web of Science ®Google Scholar
• Hankinson SE, Willett WC, Colditz GA. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393–1396.
   PubMed Web of Science ®Google Scholar
• Carboni JM, Lee AV, Hadsell DL, Rowley BR, Lee FY, Bol DK, Camuso AE, Gottardis M, Greer AF, Ho CP, Hurlburt W, Li A, Saulnier M, Velaparthi U, Wang C, Wen ML, Westhouse RA, Wittman M, Zimmermann K, Rupnow BA, Wong TW. Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor. Cancer Res 2005;65:3781–3787.
   PubMed Web of Science ®Google Scholar
• Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011 Jan;11(1):9–22.
   PubMed Web of Science ®Google Scholar